ARTICLE | Company News
Calydon other research news
January 22, 2001 8:00 AM UTC
Calydon researchers published in Cancer Research that CV787 combined with either Taxotere docetaxel or Taxol paclitaxel was synergistic in cytoxicity against prostate cancer cells as measured in a h...